logo

Beijing GoBroad Hospital

  • Home
  •  
  • Beijing GoBroad Hospital
Beijing GoBroad

Grade II General Hospital in Beijing

Beijing GoBroad Hospital

Beijing Gaobo Boren Hospital is the first flagship hospital established by Gaobo Medical Group in Beijing in 2017. As a comprehensive hospital integrating medical care, scientific research, and teaching, and a designated medical insurance institution in Beijing, the hospital features the diagnosis, treatment, and research of complex and critical diseases such as hematologic tumors, solid tumors, and brain science. It also holds the qualifications of a drug clinical trial institution and a Phase I clinical trial center, and is committed to building an integrated “clinical-research-translation” medical platform.

Clinical Departments Medical Tourism

Scale at a Glance

Est. 2017 | Grade II General Hospital | Beijing Municipal Medical Insurance Designated Institution | Bed Capacity: 170 Beds | Building Area: 14,000 m²

0
Established in BeiJing
0
Medical Departments
0
Inpatient Beds
0
m²
Hospital site area

Accredited Specialties:

Accreditations and National Recognition

Beijing GoBroad Hospital is recognized for its comprehensive medical capabilities, clinical excellence and commitment to high-quality patient care.

Grade II General Hospital

Beijing Municipal Medical Insurance Designated Hospital

Signature Disciplines

The Center for Cellular Immunotherapy of Hematologic Malignancies specializes in CAR-T cell therapy for relapsed or refractory leukemia, lymphoma, and myeloma.

Provincial Key Disciplines

The team’s research findings have been published multiple times in top-tier international academic conferences and journals, such as EHA, EBMT, and *The Lancet Oncology*.

Centers of Excellence

Center of Excellence / Department Key Highlights & Achievements Scope of Services & Specialized Fields
Hematology/Oncology Department
  • Led by Director Tong Chunrong, a pioneer in immunotherapy in China.
  • One of the earliest teams in China to adopt CAR-T therapy for acute leukemia, achieving internationally leading efficacy.
  • Internationally, the single center using the most CAR-T targets and treating the largest number of hematologic tumor patients.
  • Specializes in CAR-T sequential therapy and combining CAR-T with targeted drugs, chemotherapy, and other immunotherapies.
  • Emphasizes integrated diagnosis (cytomorphology, genetics, molecular biology) and MRD monitoring to guide personalized treatment.< /li>
  • Advocates "same disease, different treatment" and "different diseases, same treatment" concepts.
  • Diagnosis and treatment of adult and pediatric blood diseases.
  • Hematologic Tumors: Leukemia, Lymphoma, Multiple Myeloma.
  • Anemic & Bleeding Disorders: Thalassemia, Thrombocytopenia.
  • Immunotherapy: CAR-T cell therapy (CD4, CD7, CD19, CD20, CD22, CD30, CD33, CD70, CD79b, BCMA, GPRC5D); CAR-T sequential therapy; tumor cell vaccines, neoantigen vaccines, CTL, NK cell therapy.
  • Integrated Treatment: Immunotherapy, targeted therapy, transplantation, chemotherapy, TCM, radiotherapy.
Hematopoietic Stem Cell Transplantation Department
  • Led by Director Wu Tong, integrating medical treatment, teaching, and research.
  • Team leader has 26-30 years of experience; completed over 4,000 allogeneic HSCT cases with good efficacy.
  • Rich experience in transplant indications, donor selection (matched sibling, haploidentical, cord blood, autologous), individualized conditioning, and complication management (GVHD, infection, relapse).
  • Equipped with 19 hundred-level laminar flow rooms and dedicated pediatric transplant physicians.
  • Transplant Types: Allogeneic and autologous HSCT.
  • Diseases Treated: Leukemia, MDS, MDS/MPN, Lymphoma, Multiple Myeloma, Aplastic Anemia, PNH, HLH, Immunodeficiencies (X-linked Agammaglobulinemia, WAS, SCID, etc.).
  • Specialized Care: Salvage transplantation for refractory/relapsed leukemia; post-transplant immunotherapy; pediatric (as young as 2 months) and elderly (68 years) transplantation.
  • Support Services: Cell collection, separation, cryopreservation, and hematology special testing.
Pediatric Hematology/Oncology Department
  • Two major wards with approximately 70 beds; 9 full-time doctors.
  • Led by Professor Zhang Yonghong, former Director of Pediatric Lymphoma at Beijing Children's Hospital, with nearly 40 years of experience.
  • Team members trained at world-renowned institutions (St. Jude, MD Anderson, Boston Children's, Dana-Farber).
  • Nursing team led by Head Nurse Zhang Rong (30+ years of pediatric nursing experience).
  • Cure rate for newly diagnosed lymphoma/leukemia is 80-90%; 3-year EFS for Burkitt lymphoma reaches 96%.
  • Pediatric Lymphoma: Lymphoblastic, Burkitt, Anaplastic large cell, Peripheral T/NK cell, Hodgkin lymphoma.
  • Pediatric Leukemia: Acute lymphoblastic, Acute non-lymphocytic, Chronic leukemia.
  • Pediatric Solid Tumors: Neuroblastoma, Rhabdomyosarcoma, etc.
  • Other Diseases: HLH, MDS, Langerhans cell histiocytosis.
  • Advanced Treatments: Molecular stratified precision therapy, chemo-immunotherapy, HSCT, CAR-T sequential therapy bridging to HSCT.
Tumor & Immunity • Innovation Medical Center (Ward 10)
  • Led by Director Zhang Yajing, based on Gaobo's CAR-T, medical diagnosis, and HSCT platforms.
  • Beijing Clinical Sub-center of the Institute of Hematology & Blood Diseases Hospital, CAMS, collaborating with Professor Qiu Lugui's team.
  • Pioneered prospective clinical cohort studies for Multiple Myeloma in China, improving median overall survival from 27 months to about 7 years.
  • Explored CAR-T therapy for refractory/relapsed lymphoma, including humanized CAR-T salvage therapy after murine CAR-T failure.
  • Utilizes autologous transplantation combined with CAR-T therapy to significantly improve complete remission rates.
  • Refractory/Relapsed Myeloma & Lymphoma: Improving survival and cure rates.
  • CAR-T Therapy: For DLBCL, PMBCL, Burkitt lymphoma; humanized CAR-T salvage; CAR-T for CNS involvement.
  • Combined Therapy: Autologous transplantation combined with CAR-T.
  • Comprehensive Treatment: Precision diagnosis, targeted therapy, immunotherapy, high-dose chemotherapy, and HSCT.
  • Clinical Trials: International/domestic multi-center new drug trials.
Anemia Diagnosis and Treatment Center
  • Led by Dr. Jing Liping, a renowned expert formerly from the Institute of Hematology & Blood Diseases Hospital, CAMS.
  • Focuses on "precision diagnosis of difficult anemia" and "individualized treatment of complex cases".
  • Practices the concept of "precision stratification, one person one strategy" for common diseases.
  • Difficult Anemia: Precision diagnosis and individualized treatment.
  • Common Diseases: Aplastic anemia, hemolytic diseases.
  • Concept: Precision stratification, one person one strategy.
Parkinson's Disease and Movement Disorders Center
  • Gathered authoritative experts represented by Professor Chen Biao since January 2021.
  • Introduced complete assessment and detection methods for Parkinson's and movement disorders.
  • Implements full-process management: preoperative assessment, expert consultation, and postoperative follow-up.
  • Adopts a full-appointment system with time-segmented visits for a patient-centered experience.
  • Specialized Services: Gait and balance testing, olfactory testing, scale assessment, transcranial electrical stimulation, botulinum toxin injection, rehabilitation.
  • Surgical Assessment: For Parkinson's disease and dystonia.
  • Management: Preoperative assessment, expert consultation, postoperative follow-up.
Respiratory Infection and Critical Care Center
  • Led by Professor Zhang Bo, a famous respiratory and infection expert with over 20 years of experience.
  • Addresses high incidence and difficulty in differentiating pulmonary complications in hematologic tumor patients, especially post-HSCT.
  • Emphasizes multidisciplinary collaboration (hematology, respiratory, imaging, pathology, lab) for systematic management.
  • Established a preliminary management system for pulmonary complications, including diagnosis, treatment, prevention, and rehabilitation platforms.
  • Pulmonary Complication Management: Diagnosis, treatment, prevention, and rehabilitation for hematologic tumor patients.
  • Differential Diagnosis: Imaging differentiation of pulmonary infections vs. non-infectious complications.
  • Diagnostic Techniques: Imaging diagnosis of difficult lung diseases; bronchoscopy and pulmonary function tests.
  • Critical Care: Respiratory support and treatment for critical respiratory diseases.

Note: This table provides a comprehensive overview of the hospital’s specialized centers, their notable achievements, and the range of advanced procedures offered at each center.

Complete Directory of Clinical Departments

Hematology & Oncology

  • Hematology & Oncology Department
  • Hematopoietic Stem Cell Transplantation Department
  • Pediatric Hematology & Oncology Department

Specialized Clinical Centers

  • Tumor & Immunology · Innovative Medicine Center
  • Hemotherapy Center
  • Parkinson’s Disease & Movement Disorders Center
  • Respiratory Infection & Critical Care Center

Diagnostic Center

  • Clinical Laboratory
  • Integrated Diagnosis Center

Imaging & Nuclear Medicine

  • Nuclear Medicine Department
  • Medical Imaging Department

Advanced Technology & Equipment

CAR-T cell therapy

It is suitable for relapsed/refractory leukemia, lymphoma, and multiple myeloma.

Deep brain stimulation (DBS) implantation

It is used to treat Parkinson’s disease, dystonia, etc.

Hematopoietic stem cell transplantation (HSCT)

Salvage transplantation for refractory/relapsed leukemia, post-transplantation immunotherapy, and CAR-T bridging to transplantation.

MRD monitoring

Tailoring treatment based on monitoring of minimal residual disease (MRD).

Beijing GoBroad Hospital

Medical Tourism Support

International Patient Services

A dedicated office to assist with registration, coordination, and interpretation for overseas patients.

Visa Assistance

Provides official invitation letters required for medical visa applications.

Integrated Care

Coordination across departments to streamline the diagnostic and treatment process for international visitors.

Cost-Effective Care

Offers high-quality medical services at a fraction of the cost in Western countries, with transparent pricing.

Easy & Fast Access to Beijing GoBroad Hospital

Beijing GoBroad Hospital is located in Beijing, an important transportation hub in North China. The hospital is easily accessible by international flights, high-speed rail, subway, and taxi, making it convenient for both domestic and international patients to visit.

Main Campus

Building 1, Courtyard 4, Kexueyuan Road, Life Science Park, Changping District

Accessibility

Centrally located in Beijing with excellent transportation links.

From Airport

Approximately 40 minutes from Beijing Capital International Airport

From Railway

Approximately 50 minutes from Changping Station Railway Station.

Beijing GoBroad Hospital

Top-tier surgeons & specialists

Opened in July 2023 | Research-oriented hospital | Focus on hematology, oncology and brain science | 300 planned beds

WE OFFER SERVICES

Beijing City

Beijing is the capital of China and one of the most important gateway cities in North China. It is also the country’s center for politics, culture, international exchange, and technological innovation. With strong medical resources, convenient international transportation, a rich cultural heritage, and well-developed urban services, Beijing provides a supportive environment for international patients and their families coming to China for cancer treatment.

  • Economic & Medical Hub

    Beijing is an important economic and medical center in North China, with rapid development in healthcare, biotechnology, trade, logistics, and modern services.

  • International Gateway

    Beijing has Beijing Capital International Airport, Beijing Daxing International Airport, high-speed rail, subway, and road networks, providing convenient transportation for both domestic and international patients.

  • Cultural Heritage

    Beijing is a historic city with profound historical heritage, traditional cuisine, modern landmarks, and cultural attractions, offering a warm and friendly environment for visitors and families.

  • Patient-Friendly City

    Beijing combines advanced medical resources, convenient transportation, internationalized services, and comfortable urban living, providing support throughout the entire medical treatment process for patients.

In short, Beijing is a city where mountains meet the sea, tradition inspires enterprise, and a bold entrepreneurial spirit shapes the future.

Beijing GoBroad
Beijing GoBroad
Beijing GoBroad
Beijing GoBroad
Beijing GoBroad
© 2026 China Medical Services. All rights reserved.